Pravastatin prevents steroid-induced osteonecrosis in rats by suppressing PPARγ expression and activating Wnt signaling pathway. [electronic resource]
Producer: 20140514Description: 347-55 p. digitalISSN:- 1535-3699
- Adipogenesis
- Adipose Tissue -- metabolism
- Adrenal Cortex Hormones -- adverse effects
- Animals
- Core Binding Factor Alpha 1 Subunit -- genetics
- Disease Models, Animal
- Femur Head -- drug effects
- Femur Head Necrosis -- chemically induced
- Fibrinolysis -- physiology
- Hydroxymethylglutaryl-CoA Reductase Inhibitors -- therapeutic use
- Hyperlipidemias -- blood
- Lipids -- blood
- Low Density Lipoprotein Receptor-Related Protein-5 -- genetics
- Male
- Methylprednisolone
- Neovascularization, Physiologic -- drug effects
- Osteogenesis -- drug effects
- Osteonecrosis -- chemically induced
- PPAR gamma -- antagonists & inhibitors
- Pravastatin -- therapeutic use
- Rats
- Rats, Wistar
- Wnt Signaling Pathway -- drug effects
- Wnt3A Protein -- genetics
- beta Catenin -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.